EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The relationship between plasma FOXO3 and cognitive impairment and depressive symptoms in cerebral small vessel disease

Qiqi Sun, Lei Liu, Haoran Ma, Chenchen Wei, Aijun Ma

Experimental Gerontology · 2026

DOI: 10.1016/j.exger.2026.113296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Gerontology, 2026. Verfasst von Qiqi Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Forkhead Box Protein O3, Cerebral Small Vessel Diseases, Cognitive Dysfunction, Depression. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: Cerebral small vessel disease (CSVD) is a leading cause of post-stroke cognitive impairment, depression, and disability in older adults. Forkhead box O3 (FOXO3) is a key transcription factor that plays important roles in neurodegenerative and vascular diseases. This study investigated the correlation of acute-phase plasma FOXO3 levels with cognitive and depressive symptoms in CSVD patients. METHODS: This prospective cohort study recruited 183 patients with recent small subcortical infarct (RSSI) and 150 healthy controls. Plasma FOXO3 levels were measured by enzyme-linked immunosorbent assay at the acute phase (≤3 days) and day 7. Cognitive and depressive symptoms were assessed at discharge. The brain MRI was used to evaluate CSVD imaging characteristics. Mediation analysis assessed the effect of CSVD on the association between FOXO3 and cognitive function. RESULTS: Among the participants, 76 (41.53%) had cognitive impairment, and 40 (21.9%) had depressive symptoms. Plasma FOXO3 levels were profoundly higher in patients at both the acute phase (≤3 days) and day 7 compared with controls (both P < 0.001), with higher levels observed in the acute phase than at day 7 (P < 0.001). Acute-phase plasma FOXO3 was higher in patients with cognitive impairment than in those without (P < 0.001), showing a predictive area under the curve of 0.747. After adjustment, FOXO3 remained unassociated with depressive symptoms (P = 0.232). Total CSVD burden was associated with cognitive impairment (odds ratio: 1.728, 95%CI 1.084-2.756, P = 0.022). Mediation analysis showed that total CSVD burden, prominently white matter hyperintensities, mediated 36.96% of the association between FOXO3 and cognitive impairment. CONCLUSIONS: Acute-phase FOXO3 levels are associated with early cognitive impairment at discharge, whereas its long-term prognostic value requires validation in future longitudinal follow-up studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Forkhead Box Protein O3Cerebral Small Vessel DiseasesCognitive DysfunctionDepressionHumansMaleFemaleAgedProspective StudiesMagnetic Resonance ImagingMiddle AgedBiomarkersCase-Control Studies

Stichwörter der Autor:innen

BiomarkerCerebral small vessel diseasesCognitive impairmentThe forkhead box O3White matter hyperintensities

Substanzen

Forkhead Box Protein O3FOXO3 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: weichenchen2020@163.com.
  • Department of Neurology, The Affiliated Hospital of Qingdao University, Qingdao, China. Electronic address: drmaj@qdu.edu.cn.

Förderung

  • Shandong Province Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Sun, Q., Liu, L., Ma, H., Wei, C., & Ma, A. (2026). The relationship between plasma FOXO3 and cognitive impairment and depressive symptoms in cerebral small vessel disease. Experimental Gerontology. https://doi.org/10.1016/j.exger.2026.113296

Vancouver

Sun Q, Liu L, Ma H, Wei C, Ma A. The relationship between plasma FOXO3 and cognitive impairment and depressive symptoms in cerebral small vessel disease. Experimental Gerontology. 2026. doi:10.1016/j.exger.2026.113296

BibTeX
@article{Sun2026,
  author = {Sun, Qiqi and Liu, Lei and Ma, Haoran and Wei, Chenchen and Ma, Aijun},
  title = {The relationship between plasma FOXO3 and cognitive impairment and depressive symptoms in cerebral small vessel disease},
  journal = {Experimental Gerontology},
  year = {2026},
  doi = {10.1016/j.exger.2026.113296}
}
Kostenlos starten →